Zealand Pharma A/S (ZLDPF)
35.64
-1.90
(-5.05%)
USD |
OTCM |
Oct 09, 16:00
Zealand Pharma Cash from Operations (Quarterly) : 63.85M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.85M |
| March 31, 2026 | -105.24M |
| December 31, 2025 | -168.06M |
| September 30, 2025 | -32.01M |
| June 30, 2025 | 1.289B |
| March 31, 2025 | -70.65M |
| December 31, 2024 | -22.63M |
| September 30, 2024 | -43.49M |
| June 30, 2024 | -33.38M |
| March 31, 2024 | -32.56M |
| December 31, 2023 | 8.582M |
| September 30, 2023 | -16.45M |
| June 30, 2023 | -25.68M |
| March 31, 2023 | -28.35M |
| December 31, 2022 | -37.34M |
| September 30, 2022 | -17.05M |
| June 30, 2022 | -30.12M |
| March 31, 2022 | -47.80M |
| December 31, 2021 | -42.92M |
| September 30, 2021 | -30.64M |
| June 30, 2021 | -53.08M |
| March 31, 2021 | -59.62M |
| December 31, 2020 | -44.38M |
| September 30, 2020 | -15.40M |
| June 30, 2020 | -14.93M |
| Date | Value |
|---|---|
| March 31, 2020 | -31.32M |
| December 31, 2019 | -24.80M |
| September 30, 2019 | -22.43M |
| June 30, 2019 | -21.00M |
| March 31, 2019 | 7.438M |
| December 31, 2018 | -22.77M |
| September 30, 2018 | -15.58M |
| June 30, 2018 | -17.69M |
| March 31, 2018 | -15.32M |
| December 31, 2017 | -16.83M |
| September 30, 2017 | -1.372M |
| June 30, 2017 | -18.46M |
| March 31, 2017 | -7.435M |
| December 31, 2016 | 16.86M |
| September 30, 2016 | -6.872M |
| June 30, 2016 | -9.381M |
| March 31, 2016 | 6.101M |
| December 31, 2015 | -6.694M |
| September 30, 2015 | -9.080M |
| June 30, 2015 | -8.563M |
| March 31, 2015 | -9.214M |
| December 31, 2014 | -6.152M |
| September 30, 2014 | 0.941M |
| June 30, 2014 | -9.487M |
| March 31, 2014 | 7.492M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Genmab A/S | 51.04M |
| Ascendis Pharma A/S | 327.52M |
| Bavarian Nordic A/S | 55.02M |
| Evaxion AS | -- |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 34.81M |
| Cash from Financing (Quarterly) | -67.67M |
| Free Cash Flow | -253.76M |
| Free Cash Flow Per Share (Quarterly) | 0.8715 |
| Free Cash Flow to Equity (Quarterly) | 62.66M |
| Free Cash Flow to Firm (Quarterly) | 63.51M |
| Free Cash Flow Yield | -10.09% |